- Home
- EIC vs HRTX Comparison
EIC vs HRTX Comparison
Compare EIC & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EIC
- HRTX
- Stock Information
- Founded
- EIC N/A
- HRTX 1983
- Country
- EIC United States
- HRTX United States
- Employees
- EIC N/A
- HRTX N/A
- Industry
- EIC Finance/Investors Services
- HRTX Biotechnology: Pharmaceutical Preparations
- Sector
- EIC Finance
- HRTX Health Care
- Exchange
- EIC Nasdaq
- HRTX Nasdaq
- Market Cap
- EIC 348.9M
- HRTX 206.9M
- IPO Year
- EIC 2019
- HRTX 1987
- Fundamental
- Price
- EIC $13.12
- HRTX $1.24
- Analyst Decision
- EIC
- HRTX Strong Buy
- Analyst Count
- EIC 0
- HRTX 2
- Target Price
- EIC N/A
- HRTX $4.50
- AVG Volume (30 Days)
- EIC 163.6K
- HRTX 1.4M
- Earning Date
- EIC 11-13-2025
- HRTX 11-11-2025
- Dividend Yield
- EIC 11.87%
- HRTX N/A
- EPS Growth
- EIC N/A
- HRTX N/A
- EPS
- EIC 0.70
- HRTX N/A
- Revenue
- EIC $55,581,156.00
- HRTX $149,694,000.00
- Revenue This Year
- EIC $37.84
- HRTX $10.62
- Revenue Next Year
- EIC $23.33
- HRTX $12.99
- P/E Ratio
- EIC $18.88
- HRTX N/A
- Revenue Growth
- EIC 56.39
- HRTX 9.78
- 52 Week Low
- EIC $12.10
- HRTX $1.04
- 52 Week High
- EIC $16.71
- HRTX $2.68
- Technical
- Relative Strength Index (RSI)
- EIC 41.86
- HRTX 30.45
- Support Level
- EIC $13.05
- HRTX $1.25
- Resistance Level
- EIC $13.45
- HRTX $1.35
- Average True Range (ATR)
- EIC 0.18
- HRTX 0.06
- MACD
- EIC -0.07
- HRTX 0.01
- Stochastic Oscillator
- EIC 8.17
- HRTX 5.00
About EIC Eagle Point Income Company Inc.
Eagle Point Income Co Inc is a closed-end management investment company. Its primary investment objective is to generate high current income, with a secondary objective to generate capital appreciation. The Company seeks to achieve its investment objectives by investing in junior debt tranches of collateralized loan obligations, or "CLOs," that are collateralized by a portfolio consisting of below-investment grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.